National Institutes of Health, National Institute of Allergy and Infectious Diseases, Contract Management Branch, Solar Bldg., Room 3C07, 6003 Executive Blvd. MSC 7610, Bethesda, MD 20892-7610

A -- CLINICAL TRIALS OF THERAPIES FOR SEVERE HERPESVIRUS INFECTIONS SOL NO1-AI-15113 DUE 032495 POC Carl Henn, Contracting Officer, (301) 496-0993. The National Institute of Allergy and Infectious Diseases intends to negotiate with the University of Alabama at Birmingham to perform work on the Hantavirus under contract NO1-AI-15113 for Clinical Trials of Therapies for Severe Herpesvirus Infections. This effort provides for the performance of the clinical trial ''A Collaborative Double-Blind Placebo Controlled Trial of Intravenous Ribavirin as a Treatment for Presumed Hantavirus Pulmonary Syndrome''. Authority: 41 USC 253(c)(1) as set forth in FAR 6.302-1. Only the University of Alabama has the capability of performing this work in the given time frame and on such short notice. This effort will be recompeted when contract NO1-AI-15113 expires on June 30, 1996. See Numbered Note 22. (0034)

Loren Data Corp. http://www.ld.com (SYN# 0006 19950206\A-0006.SOL)